The settlement benefits consumers covered under self-funded or fully insured ERISA health plans administered by UnitedHealthcare whose claims for specialized liposuction for lipedema were denied as unproven between Jan. 1, 2015, and Dec. 31, 2019. The settlement also benefits a damages subclass of patients who paid for liposuction themselves after it was deemed “unproven” for lipedema treatment.
